Bio & Healthcare Archives | Be Korea-savvy

Archive by category Bio & Healthcare

Celltrion’s New Autoimmune Disease Treatment Zymfentra Hits U.S. Market

Celltrion’s New Autoimmune Disease Treatment Zymfentra Hits U.S. Market

SEOUL, Mar. 18 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. said Monday its new autoimmune disease treatment, Zymfentra, has made a debut in the U.S. market. Zymfentra, a subcutaneous injection formulation of Celltrion’s infliximab Remsima, won approval from the U.S. Food and Drug Administration last year for use on patients who suffer ulcerative [...]

South Korea Expands Mail-Back Program for Disposal of Unused Medication

South Korea Expands Mail-Back Program for Disposal of Unused Medication

SEOUL, Mar. 18 (Korea Bizwire) – South Korea is set to significantly expand a program that allows residents to safely dispose of expired or unwanted medication simply by dropping it into a mailbox, reducing environmental hazards from improper disposal.  According to the Ministry of Environment, as many as 43 municipal governments across the country could adopt [...]

Government to Unveil Financial Ties Between Doctors and Pharma, Amid Privacy Concerns

Government to Unveil Financial Ties Between Doctors and Pharma, Amid Privacy Concerns

SEOUL, Mar. 15 (Korea Bizwire) – The South Korean government is gearing up to disclose a report by year-end that will reveal the financial benefits received by doctors from pharmaceutical companies, sparking a debate on whether to include identifiable information such as names in the report. According to a statement from the Ministry of Health and [...]

Lunit Gets New Zealand Court’s Preliminary Approval on Acquisition of Volpara Health

Lunit Gets New Zealand Court’s Preliminary Approval on Acquisition of Volpara Health

SEOUL, Mar. 13 (Korea Bizwire) — Lunit Inc., a South Korean medical artificial intelligence (AI) startup, said Wednesday it has secured preliminary approval from a New Zealand high court for the acquisition of an Oceania-based breast cancer solution firm, Volpara Health Ltd. With the high court’s approval, Volpara Health will hold a general shareholders’ meeting [...]

Korean Companies Mixed on Future Prospects Amid Global Industry Shifts, Survey Reveals

Korean Companies Mixed on Future Prospects Amid Global Industry Shifts, Survey Reveals

SEOUL, Feb. 29 (Korea Bizwire) – Amid a worldwide shake-up of industrial sectors, Korean firms are experiencing a range of emotions about the future of their key operations, feelings that vary widely depending on the size of the business and the industry it belongs to. A recent survey conducted by the Korea Chamber of Commerce and [...]

Pharmaceutical Industry Embraces Character Marketing to Soften Image and Engage Younger Audiences

Pharmaceutical Industry Embraces Character Marketing to Soften Image and Engage Younger Audiences

SEOUL, Feb. 11 (Korea Bizwire) –The pharmaceutical sector is making a strategic shift towards character marketing, breaking away from its traditionally rigid image to appeal to a broader demographic, including the younger generation. Historically, character marketing in the pharmaceutical industry was primarily limited to children’s medications. However, recent trends indicate an expansion towards engaging younger [...]

Korea Exchange to List Samsung Asset Management’s First Obesity Treatment-Themed ETF

Korea Exchange to List Samsung Asset Management’s First Obesity Treatment-Themed ETF

SEOUL, Feb. 9 (Korea Bizwire) –The Korea Exchange announced on February 8 that it will list Samsung Asset Management’s KODEX Global Obesity Treatment TOP2 Plus Exchange Traded Fund (ETF) on the stock market on February 14. This fund marks the first obesity treatment-themed product in South Korea, investing in 10 global companies related to obesity [...]

Samsung Biologics Offers Up to 100 Million KRW in Total Compensation for New Hires

Samsung Biologics Offers Up to 100 Million KRW in Total Compensation for New Hires

SEOUL, Jan. 31 (Korea Bizwire) –Samsung Biologics has disclosed that the total compensation package for its employees, including wages and benefits, can reach up to 100 million KRW annually for first-year employees. On January 31, it was revealed that Samsung Biologics had shared a “Total Compensation Statement” with its employees for the first time, detailing [...]

Korean Research Team Develops Innovative Organ-on-a-Chip for Efficient Chronic Inflammation Analysis and Drug Efficacy Evaluation

Korean Research Team Develops Innovative Organ-on-a-Chip for Efficient Chronic Inflammation Analysis and Drug Efficacy Evaluation

SEOUL, Jan. 16 (Korea Bizwire) — The Korea Research Institute of Chemical Technology (KRICT) announced on January 15 that a team led by Dr. Lee Seong-gyun and Dr. Kim Hong-ki has developed new biomimetic organ-on-a-chip technology. This platform is expected to be highly effective in analyzing chronic inflammation in patients and evaluating the efficacy of therapeutics. Organ-on-a-chip [...]

South Korean Pharmaceutical Companies Eye ‘Medifood’ as a New Growth Engine Amid Aging Society

South Korean Pharmaceutical Companies Eye ‘Medifood’ as a New Growth Engine Amid Aging Society

SEOUL, Jan. 15 (Korea Bizwire) — As South Korea grapples with an aging population, pharmaceutical companies are increasingly looking at ‘medifood’ as a potential new growth area. Medifood, also known as ‘food for special medical purposes,’ includes beverages and meals specially designed for the elderly or others who require particular nutritional care due to health reasons. On [...]